GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (FRA:J4D) » Definitions » Short Percentage of Float

Kenvue (FRA:J4D) Short Percentage of Float


View and export this data going back to 2023. Start your Free Trial

What is Kenvue Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Kenvue's Short Percentage of Float

For the Household & Personal Products subindustry, Kenvue's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kenvue's Short Percentage of Float Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kenvue's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Kenvue's Short Percentage of Float falls into.


;
;

Kenvue Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (FRA:J4D) » Definitions » Short Percentage of Float
Comparable Companies
KMB CHD EL CLX CL HIMS COTY IPAR ELF NWL PG XPAR:OR LSE:ULVR BOM:500696 LSE:RKT XTER:HEN3 XTER:BEI TSE:4452 OSTO:ESSITY B TSE:8113
Traded in Other Exchanges
KVUE:USA J4D:Germany
Address
199 Grandview Road, Skillman, NJ, USA, 08558
Website
https://www.kenvue.com
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Kenvue Headlines

No Headlines